StonvexLoading…
StonvexStonvexStonvexCore line items from HIPO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $121.50M | $468.60M | $348.20M | $227.60M |
Operating Income | $7.20M | $63.30M | $56.50M | $-41.60M |
Net Income | $7.10M | $57.70M | $51.70M | $-46.40M |
EPS (Diluted) | $0.27 | $2.22 | $1.97 | $-1.84 |
Total Assets | $2.06B | $1.91B | $1.87B | $1.71B |
Total Liabilities | $1.61B | $1.47B | $1.45B | $1.37B |
Cash & Equivalents | $275.40M | $218.30M | $247.70M | $198.90M |
Free Cash Flow OCF − CapEx | $8.40M | $9.10M | $5.90M | $-10.90M |
Shares Outstanding | 26.04M | 25.70M | 26.19M | 25.54M |